EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fractional erbium-doped yttrium aluminum garnet laser-assisted drug delivery: impact of triamcinolone acetonide formulation on drug permeation

Premrutai Thitilertdecha iD, Teerapat Wannawittayapa, Panyapat Buranaporn, Cyryl Rae Benjamine Santiago Rejuso-Kalbit, Rosalyn Kupwiwat, Poonsin Poungpairoj, Varangkana Tantithavorn, Nattawat Onlamoon, Woraphong Manuskiatti

Drug Delivery and Translational Research · 2025-11 · 15 (11) · 3783-3792

DOI: 10.1007/s13346-024-01771-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Delivery and Translational Research, online erschienen am 24.12.2024. Verfasst von Premrutai Thitilertdecha und 8 weiteren Autor:innen. Beteiligte Einrichtung: Siriraj Research Group in Immunobiology and Therapeutic Sciences, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Triamcinolone Acetonide, Lasers, Solid-State, Drug Delivery Systems. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mahidol University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ablative fractional laser-assisted drug delivery has gained attention as a promising method for enhancing dermal drug absorption and improving therapeutic outcomes in dermatological conditions, particularly for hypertrophic and keloid scars. However, despite the growing number of clinical trials and case reports supporting its efficacy, there remains a scarcity of robust evidence on the topical bioavailability and dermato-pharmacokinetics of drugs in human subjects. This study aimed to examine the enhancement of triamcinolone acetonide (TAC) bioavailability following treatment with a fractional Erbium-Doped Yttrium Aluminum Garnet (Er: YAG) laser. Stratum corneum (SC) uptake and transport of TAC from 0.1% TAC cream and 10 mg/mL TAC solution/suspension with and without the laser pre-treatment were determined through tape stripping method for SC collection. TAC therein was quantified by an ultra-performance liquid chromatography coupled with photodiode array (UPLC-PDA) detection. TAC from both formulations without laser assistance was percutaneously absorbed within 6 h and TAC was delivered out from the solution to the SC remarkably higher. When the skin was pre-treated with the laser, permeability of TAC from the solution was escalated by 5 folds. TAC distribution profiles in the SC also confirmed this increased drug uptake, mainly the outer skin layers. On the other hand, amounts of absorbed TAC and their distribution patterns from the cream remained unchanged and low. No adverse events and unbearable pain were observed throughout the experiments. The fractional Er: YAG laser enhanced the dermal absorption of TAC, but this effect was confined to the solution formulation, with no significant improvement seen in the cream. This finding highlights the critical role that drug formulation plays in laser-assisted drug delivery. Moreover, factors such as drug selection, laser type, and optimal laser settings may also impact the efficacy of this approach and require further exploration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triamcinolone AcetonideLasers, Solid-StateDrug Delivery SystemsSkin AbsorptionSkinAnimalsAdministration, CutaneousPermeabilityBiological AvailabilityHumansSwine

Stichwörter der Autor:innen

Dermal absorptionFractional Er:YAG laserFractional ablative laserTopical bioavailabilityTriamcinolone acetonide

Substanzen

Triamcinolone Acetonide

Autor:innen und Institutionen

  • Siriraj Research Group in Immunobiology and Therapeutic Sciences, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Wanglang Road, Bangkoknoi, Bangkok, 10700, Thailand.
  • Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Wanglang Road, Bangkoknoi, Bangkok, 10700, Thailand. doctorlaser@gmail.com.

ORCID-Profile: Premrutai Thitilertdecha

Förderung

  • Mahidol University

Zitieren

APA

Thitilertdecha, P., Wannawittayapa, T., Buranaporn, P., Rejuso-Kalbit, C. R. B. S., Kupwiwat, R., Poungpairoj, P., Tantithavorn, V., Onlamoon, N., & Manuskiatti, W. (2025). Fractional erbium-doped yttrium aluminum garnet laser-assisted drug delivery: impact of triamcinolone acetonide formulation on drug permeation. Drug Delivery and Translational Research, 15(11), 3783-3792. https://doi.org/10.1007/s13346-024-01771-y

Vancouver

Thitilertdecha P, Wannawittayapa T, Buranaporn P, Rejuso-Kalbit CRBS, Kupwiwat R, Poungpairoj P, et al. Fractional erbium-doped yttrium aluminum garnet laser-assisted drug delivery: impact of triamcinolone acetonide formulation on drug permeation. Drug Delivery and Translational Research. 2025;15(11):3783-3792. doi:10.1007/s13346-024-01771-y

BibTeX
@article{Thitilertdecha2025,
  author = {Thitilertdecha, Premrutai and Wannawittayapa, Teerapat and Buranaporn, Panyapat and Rejuso-Kalbit, Cyryl Rae Benjamine Santiago and Kupwiwat, Rosalyn and Poungpairoj, Poonsin and Tantithavorn, Varangkana and Onlamoon, Nattawat and Manuskiatti, Woraphong},
  title = {Fractional erbium-doped yttrium aluminum garnet laser-assisted drug delivery: impact of triamcinolone acetonide formulation on drug permeation},
  journal = {Drug Delivery and Translational Research},
  year = {2025},
  volume = {15},
  number = {11},
  pages = {3783--3792},
  doi = {10.1007/s13346-024-01771-y}
}
Kostenlos starten →